OX1 Receptor Antagonists Patent Application
Summary
The USPTO has published a new patent application (US20260085056A1) filed on May 9, 2025, by NXERA PHARMA UK LIMITED. The application relates to novel compounds for treating neurological or psychiatric disorders associated with orexin receptors.
What changed
This document is a publication of a new patent application, US20260085056A1, filed by NXERA PHARMA UK LIMITED on May 9, 2025. The application discloses novel compounds of formula (I) and their use in treating neurological or psychiatric disorders associated with orexin receptors.
As this is a patent application publication, it does not impose new regulatory obligations or compliance deadlines on regulated entities. It serves as a notice of intellectual property filing related to pharmaceutical research and development in the area of neurological and psychiatric disorders.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
OX1 RECEPTOR ANTAGONISTS
Application US20260085056A1 Kind: A1 Mar 26, 2026
Assignee
NXERA PHARMA UK LIMITED
Inventors
Giles Albert BROWN, Miles Stuart CONGREVE, John Andrew CHRISTOPHER, Nigel Alan SWAIN, Sarah Joanne BUCKNELL, Anne Mary STEPHENSON, Benjamin Gerald TEHAN, Mark MILLS, Anil PATEL
Abstract
The disclosures herein relate to novel compounds of formula (I); and salts thereof, wherein W; X; Y; Z; R1; R2; R3 and R4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
CPC Classifications
C07D 401/04 C07D 239/26 C07D 241/12 C07D 401/12
Filing Date
2025-05-09
Application No.
19203332
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.